Testing lower bleomycin dose in electrochemotherapy
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests if a lower dose of the drug bleomycin works as well in electrochemotherapy for skin or under-the-skin tumors. The goal is to reduce side effects while still treating cancer effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a tumor in or under the skin that has been confirmed by a biopsy.
- Your doctor expects you to live at least 3 more months.
- You can continue other cancer treatments like chemotherapy or immunotherapy during the trial.
- If you have had electrochemotherapy before, it has been at least 3 months for the tumors we want to treat.
- You must use effective birth control if you are sexually active.
- You do not have a severe lung infection or poor lung function.
- You are not allergic to bleomycin.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called bleomycin electrosclerotherapy for people with slow-flow vascular malformations (abnormal blood vessels that do not flow quickly). The goal is to see if this treatment works well and is safe for these conditions.
This trial tests a treatment called electrochemotherapy for tumors in internal organs (like the liver or pancreas) when standard treatments are no longer possible. It uses a drug called bleomycin plus electric pulses to target cancer cells.
This Phase 2 study tests electrotherapy (a way to help treatment reach tumor cells) for gynecologic cancers that have come back after standard treatments were used up. You may be considered if your overall health allows anesthesia and if certain cancer spread and medical safety issues do not apply.
This trial tests a treatment called bleomycin electrosclerotherapy (BEST) for low-flow vascular malformations—abnormal blood vessel or lymph vessel growths that haven't responded well to previous treatments. The treatment involves injecting bleomycin (a medication) directly into the malformation and using electrical current to help destroy it.
This study tests if electrochemotherapy can change the environment around melanoma tumors. It may help patients with melanoma that has spread to the skin or just under the skin.
This study tests how electrochemotherapy (ECT) changes the area around melanoma tumors in the skin. It may help doctors understand why ECT works and who benefits most.
Hear when a new Cutaneous Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.